Purchases and Sales Made in Q3 2023 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q3 2023. The information is specifically focused on institutions that hold shares of Adaptimmune Therapeutics PLC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Long Focus Capital Management, LLC
San Juan, PR |
BUY
|
- |
3.15M+ 40.33% |
$2.3M - $3.28M
|
11M
$6.58M
|
|
|
Nov 14, 2023
Q3 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
BUY
|
- |
2.07M+ 24.72% |
$1.51M - $2.15M
|
10.4M
$6.25M
|
|
|
Oct 27, 2023
Q3 2023
|
Acuitas Investments, LLC
|
BUY
|
- |
480KNew |
$350K - $499K
|
480K
$288K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
179K+ 5.33% |
$131K - $187K
|
3.55M
$2.13M
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
104K+ 8.95% |
$75.9K - $108K
|
1.27M
$760K
|
|
|
Oct 27, 2023
Q3 2023
|
Marquette Asset Management, LLC
|
BUY
|
- |
99.3KNew |
$72.5K - $103K
|
99.3K
$59.6K
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
41.6K+ 260.54% |
$30.4K - $43.3K
|
57.6K
$34.6K
|
|
|
Nov 02, 2023
Q3 2023
|
Main Street Financial Solutions, LLC
|
BUY
|
- |
31.2KNew |
$22.8K - $32.4K
|
31.2K
$18.7K
|
|
|
Nov 13, 2023
Q3 2023
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
30.2KNew |
$22.1K - $31.4K
|
30.2K
$18.1K
|
|
|
Oct 20, 2023
Q3 2023
|
Harbor Capital Advisors, Inc.
|
BUY
|
- |
21.9K+ 19.46% |
$16K - $22.8K
|
134K
$80.6K
|
|
|
Nov 14, 2023
Q3 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
18.9K+ 11865.41% |
$13.8K - $19.6K
|
19K
$11.4K
|
|
|
Nov 13, 2023
Q3 2023
|
Pro Share Advisors LLC
|
BUY
|
- |
13.5KNew |
$9.83K - $14K
|
13.5K
$8.08K
|
|
|
Oct 13, 2023
Q3 2023
|
Courier Capital LLC
|
BUY
|
- |
12KNew |
$8.76K - $12.5K
|
12K
$7.2K
|
|
|
Nov 13, 2023
Q3 2023
|
Invesco Ltd.
Atlanta, GA |
BUY
|
- |
10.9K+ 31.19% |
$7.97K - $11.4K
|
45.9K
$27.5K
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
9.53K+ 19.83% |
$6.96K - $9.92K
|
57.6K
$34.6K
|
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
8.2K+ 363.15% |
$5.99K - $8.53K
|
10.5K
$6.27K
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
8.13K+ 2.79% |
$5.93K - $8.45K
|
299K
$179K
|
|
|
Oct 30, 2023
Q3 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
3.37K+ 175.55% |
$2.46K - $3.5K
|
5.29K
$3.17K
|
|
|
May 21, 2024
Q3 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
3.37K+ 175.55% |
$2.46K - $3.5K
|
5.29K
$3.17K
|
|
|
Oct 30, 2023
Q3 2023
|
Sandy Spring Bank
|
BUY
|
- |
1.05KNew |
$767 - $1.09K
|
1.05K
$630
|
|
|
Nov 14, 2023
Q3 2023
|
Lazard Asset Management LLC
New York, NY |
BUY
|
- |
185+ 4.44% |
$135 - $192
|
4.35K
$2.61K
|
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
BUY
|
- |
79+ 0.01% |
$57.7 - $82.2
|
582K
$349K
|
|
|
Aug 14, 2024
Q3 2023
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
BUY
|
- |
30+ 3.97% |
$21.9 - $31.2
|
785
$471
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 24, 2023
Q3 2023
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-80- 0.77% |
$58.4 - $83.2
|
10.4K
$6.22K
|
|
|
Nov 01, 2023
Q3 2023
|
Investors Research Corp
|
SELL
|
- |
-100- 50.0% |
$73 - $104
|
100
$60
|
|
|
Nov 13, 2023
Q3 2023
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-107- 0.41% |
$78.1 - $111
|
26.1K
$15.6K
|
|
|
Oct 18, 2023
Q3 2023
|
High Mark Wealth Management LLC
|
SELL
|
- |
-982- 77.38% |
$717 - $1.02K
|
287
$172
|
|
|
Nov 14, 2023
Q3 2023
|
Bayesian Capital Management, LP
Brooklyn, NY |
SELL
|
- |
-1.1K- 9.49% |
$803 - $1.14K
|
10.5K
$6.29K
|
|
|
Nov 13, 2023
Q3 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-1.35K- 2.29% |
$983 - $1.4K
|
57.4K
$34.5K
|
|
|
Nov 09, 2023
Q3 2023
|
Hunter Associates Investment Management LLC
Pittsburgh, PA |
SELL
|
- |
-1.5K- 5.88% |
$1.1K - $1.56K
|
24K
$14.4K
|
|
|
Oct 16, 2023
Q3 2023
|
Douglas Lane & Associates, LLC
|
SELL
|
- |
-2K- 15.38% |
$1.46K - $2.08K
|
11K
$6.6K
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-2.65K- 8.54% |
$1.93K - $2.75K
|
28.3K
$17K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-5.49K- 9.12% |
$4.01K - $5.71K
|
54.7K
$32.8K
|
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-8.04K- 50.0% |
$5.87K - $8.36K
|
8.04K
$4.82K
|
|
|
Nov 14, 2023
Q3 2023
|
Key Client Fiduciary Advisors, LLC
|
SELL
|
- |
-12.8K- 3.9% |
$9.37K - $13.3K
|
316K
$190K
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-14.7K- 8.1% |
$10.7K - $15.3K
|
167K
$100K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-25.8K- 1.24% |
$18.9K - $26.9K
|
2.05M
$1.23M
|
|
|
Nov 13, 2023
Q3 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-28.7K- 0.17% |
$21K - $29.9K
|
17.1M
$10.3M
|
|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-32.5K- 33.53% |
$23.7K - $33.8K
|
64.4K
$38.7K
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-50.1K- 45.47% |
$36.6K - $52.1K
|
60.1K
$36K
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-78.6K- 78.47% |
$57.4K - $81.7K
|
21.6K
$12.9K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-273K- 20.96% |
$200K - $284K
|
1.03M
$619K
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-479K- 31.77% |
$349K - $498K
|
1.03M
$617K
|